Maze Therapeutics Stock Still Up 180% After March Tumble. One Fund Just Disclosed Selling $3 Million in Shares

Maze Therapeutics Stock Still Up 180% After March Tumble. One Fund Just Disclosed Selling $3 Million in Shares

Key PointsHighVista Strategies sold 70,503 shares of Maze Therapeutics in the first quarter; the estimated trade value was $3.11 million.Meanwhile, the quarter-end position value decreased by $4.08 million, reflecting changes from both trading and price movement.The estimated transaction was 0.86% of 13F reportable assets under management (AUM).10 stocks we like better than Maze Therapeutics › On May 15, 2026, HighVista Strategies disclosed it s…